Curtis T. Keith

Direttore/Membro del Consiglio presso Translational Development Acquisition Corp.

53 anni

Consumer Services

Health Technology

Finance

Profilo

Curtis T.
Keith was the founder of CombinatoRx, Inc. which was founded in 2000, where he held the title of Senior Vice President-Research from 2000 to 2008.
Currently, he is a Director at Translational Development Acquisition Corp.
Dr. Keith's education history includes a graduate and doctorate degree from Harvard University and an undergraduate degree from McGill University.

Posizioni attive di Curtis T. Keith

Società	Posizione	Inizio
Translational Development Acquisition Corp. Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Curtis T. Keith

Precedenti posizioni note di Curtis T. Keith

Società	Posizione	Fine
CombinatoRx, Inc. CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA	Fondatore	07/02/2008

Vedi nel dettaglio l'esperienza di Curtis T. Keith

Formazione di Curtis T. Keith

Harvard University	Doctorate Degree
McGill University	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Curtis T. Keith

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
CombinatoRx, Inc. CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA	Health Technology
Translational Development Acquisition Corp. Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.	Finance